Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12654)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2014 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zelber-Sagi S, Buch A, Yeshua H, Vaisman N, Webb M, Harari G, Kis O, Fliss-Isakov N, Izkhakov E, Halpern Z, Santo E, Oren R, Shibolet O. Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial. World J Gastroenterol 2014; 20(15): 4382-4392 [PMID: 24764677 DOI: 10.3748/wjg.v20.i15.4382] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v20/i15/4382.htm |
| Number | Citing Articles |
| 1 |
C. Moctezuma-Velázquez. Tratamiento actual de la enfermedad por hígado graso no alcohólico. Revista de Gastroenterología de México 2018; 83(2): 125 doi: 10.1016/j.rgmx.2017.10.003
|
| 2 |
Hirokazu Takahashi, Kazuhiko Kotani, Kenichi Tanaka, Yuichiro Egucih, Keizo Anzai. Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00588
|
| 3 |
Robson Damasceno de Lima, Renan Fudoli Lins Vieira, Vitor Rosetto Muñoz, Amandine Chaix, Ana Paula Azevedo Macedo, Gabriel Calheiros Antunes, Maíra Felonato, Renata Rosseto Braga, Susana Castelo Branco Ramos Nakandakari, Rafael Calais Gaspar, Adelino Sanchez Ramos da Silva, Dennys Esper Cintra, Leandro Pereira de Moura, Rania A. Mekary, Eduardo Rochete Ropelle, José Rodrigo Pauli. Time-restricted feeding combined with resistance exercise prevents obesity and improves lipid metabolism in the liver of mice fed a high-fat diet. American Journal of Physiology-Endocrinology and Metabolism 2023; 325(5): E513 doi: 10.1152/ajpendo.00129.2023
|
| 4 |
Oliver Glass, Akash Radia, William Kraus, Manal Abdelmalek. Exercise Training as Treatment of Nonalcoholic Fatty Liver Disease. Journal of Functional Morphology and Kinesiology 2017; 2(4): 35 doi: 10.3390/jfmk2040035
|
| 5 |
Audrey Thorp, Jonathan G. Stine. Exercise as Medicine: The Impact of Exercise Training on Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2020; 19(4): 402 doi: 10.1007/s11901-020-00543-9
|
| 6 |
Parvin Farzanegi, Amir Dana, Zeynab Ebrahimpoor, Mahdieh Asadi, Mohammad Ali Azarbayjani. Mechanisms of beneficial effects of exercise training on non‐alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. European Journal of Sport Science 2019; 19(7): 994 doi: 10.1080/17461391.2019.1571114
|
| 7 |
Sechang Oh, Natsumi Oshida, Noriko Someya, Tsuyoshi Maruyama, Tomonori Isobe, Yoshikazu Okamoto, Taeho Kim, Bokun Kim, Junichi Shoda. Whole‐body vibration for patients with nonalcoholic fatty liver disease: a 6‐month prospective study. Physiological Reports 2019; 7(9): e14062 doi: 10.14814/phy2.14062
|
| 8 |
Sheila Maier, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan, Miguel A. Lanaspa, Richard J. Johnson, Thomas Jensen. Lean NAFLD: an underrecognized and challenging disorder in medicine. Reviews in Endocrine and Metabolic Disorders 2021; 22(2): 351 doi: 10.1007/s11154-020-09621-1
|
| 9 |
Jae Ho Park, Nam-Kyoo Lim, Hyun-Young Park. Protective Effect of Leisure-Time Physical Activity and Resistance Training on Nonalcoholic Fatty Liver Disease: A Nationwide Cross-Sectional Study. International Journal of Environmental Research and Public Health 2022; 19(4): 2350 doi: 10.3390/ijerph19042350
|
| 10 |
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease. Clínica e Investigación en Arteriosclerosis (English Edition) 2017; 29(4): 185 doi: 10.1016/j.artere.2017.07.001
|
| 11 |
Stephan C. Bischoff, William Bernal, Srinivasan Dasarathy, Manuela Merli, Lindsay D. Plank, Tatjana Schütz, Mathias Plauth. ESPEN practical guideline: Clinical nutrition in liver disease. Clinical Nutrition 2020; 39(12): 3533 doi: 10.1016/j.clnu.2020.09.001
|
| 12 |
Juanjuan Wen, Haiyan Zhou, Lirong Zeng. Comment on: Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis. Digestive and Liver Disease 2023; 55(11): 1573 doi: 10.1016/j.dld.2023.07.022
|
| 13 |
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento (II). Tratamiento de la enfermedad del hígado graso no alcohólico. Clínica e Investigación en Arteriosclerosis 2017; 29(4): 185 doi: 10.1016/j.arteri.2016.06.002
|
| 14 |
Amit Kumar Singh, Navneet Kaur, Sushant Kaushal, Rahul Tyagi, Deepali Mathur, Madhava Sai Sivapuram, Kashinath Metri, Sridhar Bammidi, Vivek Podder, Shweta Modgil, Radhika Khosla, Kiran Sharma, Abhilasha Anand, Neeru Malik, VidhyaSagar Boroiah, Raghuram Nagarathna, Hongasandra R. Nagendra, Akshay Anand. Partitioning of radiological, stress and biochemical changes in pre-diabetic women subjected to Diabetic Yoga Protocol. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(4): 2705 doi: 10.1016/j.dsx.2019.07.007
|
| 15 |
Mathias Plauth, William Bernal, Srinivasan Dasarathy, Manuela Merli, Lindsay D. Plank, Tatjana Schütz, Stephan C. Bischoff. ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition 2019; 38(2): 485 doi: 10.1016/j.clnu.2018.12.022
|
| 16 |
Katherine T. Brunner, Cameron J. Henneberg, Robert M. Wilechansky, Michelle T. Long. Nonalcoholic Fatty Liver Disease and Obesity Treatment. Current Obesity Reports 2019; 8(3): 220 doi: 10.1007/s13679-019-00345-1
|
| 17 |
William N. Hannah, Stephen A. Harrison. Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2016; 61(5): 1365 doi: 10.1007/s10620-016-4153-y
|
| 18 |
Sedhunivas R., Chandramohan R.. “Anthropometric measurements and exercise interventions in non-alcoholic fatty liver disease patients”: a literature review. Bulletin of Faculty of Physical Therapy 2024; 29(1) doi: 10.1186/s43161-023-00164-5
|
| 19 |
Lais S Garcêz, Camila R Avelar, Nedja S S Fonseca, Priscila R F Costa, André C Lyra, Carla M Cunha, Rosangela P Jesus, Lucivalda P M Oliveira. Effect of dietary carbohydrate and lipid modification on clinical and anthropometric parameters in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutrition Reviews 2021; 79(12): 1321 doi: 10.1093/nutrit/nuaa146
|
| 20 |
Susan Kenneally, Joanna H Sier, J Bernadette Moore. Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review. BMJ Open Gastroenterology 2017; 4(1): e000139 doi: 10.1136/bmjgast-2017-000139
|
| 21 |
Jiaren Wang, Lin Zeng, Chang Hong, Hao Cui, Weizhen Wang, Hongbo Zhu, Qimei Li, Yan Li, Ruining Li, Jingzhe He, Hong Zhu, Li Liu, Lushan Xiao. Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross‐sectional and prospective study of 368,634 UK Biobank participants. Clinical Endocrinology 2024; 100(2): 116 doi: 10.1111/cen.14990
|
| 22 |
Andrea Gonzalez, Mayalen Valero-Breton, Camila Huerta-Salgado, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis. European Journal of Translational Myology 2021; doi: 10.4081/ejtm.2020.9630
|
| 23 |
Hao Wang, Qianqian Ma, Youpeng Chen, Ling Luo, Junzhao Ye, Bihui Zhong. Optimized strategy among diet, exercise, and pharmacological interventions for nonalcoholic fatty liver disease: A network meta‐analysis of randomized controlled trials. Obesity Reviews 2024; doi: 10.1111/obr.13727
|
| 24 |
Lorenzo A. Orci, Karim Gariani, Graziano Oldani, Vaihere Delaune, Philippe Morel, Christian Toso. Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression. Clinical Gastroenterology and Hepatology 2016; 14(10): 1398 doi: 10.1016/j.cgh.2016.04.036
|
| 25 |
Ariel Vivero, Manuel Ruz, Matías Rivera, Karen Miranda, Camila Sacristán, Alejandra Espinosa, Juana Codoceo, Jorge Inostroza, Karla Vásquez, Álvaro Pérez, Diego García-Díaz, Miguel Arredondo. Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver. Biological Trace Element Research 2021; 199(6): 2215 doi: 10.1007/s12011-020-02324-3
|
| 26 |
Amel Ait Boudaoud, Claire Rives-Lange, Jean François Perregaux, Alina Radu, Diane Messager-Josipowicz, Charles Barsamian, Claire Carette, Sébastien Czernichow. Interventions nutritionnelles dans la prise en charge de la stéatose et la stéatohépatite non alcoolique. La Presse Médicale 2019; 48(12): 1496 doi: 10.1016/j.lpm.2019.10.026
|
| 27 |
Shelley E Keating, Jacob George, Nathan A Johnson. The benefits of exercise for patients with non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2015; 9(10): 1247 doi: 10.1586/17474124.2015.1075392
|
| 28 |
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese. Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management. Advances in Therapy 2021; 38(5): 2130 doi: 10.1007/s12325-021-01690-1
|
| 29 |
Nermeen N. El-Agroudy, Anica Kurzbach, Roman N. Rodionov, John O’Sullivan, Michael Roden, Andreas L. Birkenfeld, Dominik H. Pesta. Are Lifestyle Therapies Effective for NAFLD Treatment?. Trends in Endocrinology & Metabolism 2019; 30(10): 701 doi: 10.1016/j.tem.2019.07.013
|
| 30 |
Shu-ting Wang, Jing Zheng, He-wei Peng, Xiao-lin Cai, Xin-ting Pan, Hui-quan Li, Qi-zhu Hong, Xian-E Peng. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01204-3
|
| 31 |
Jonathan G. Stine, Ian R. Schreibman, Alison J. Faust, Jessica Dahmus, Benjamin Stern, Christopher Soriano, Gloriany Rivas, Breianna Hummer, Scot R. Kimball, Nate R. Geyer, Vernon M. Chinchilli, Rohit Loomba, Kathryn Schmitz, Christopher Sciamanna. NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH. Hepatology 2022; 76(1): 172 doi: 10.1002/hep.32274
|
| 32 |
Mathias Plauth. Comprehensive Guide to Hepatitis Advances. 2023; : 87 doi: 10.1016/B978-0-323-98368-6.00004-5
|
| 33 |
Jonathan G. Stine, Michelle T. Long, Kathleen E. Corey, Robert E. Sallis, Alina M. Allen, Matthew J. Armstrong, David E. Conroy, Daniel J. Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J. Hickman, Matthew R. Kappus, Shelley E. Keating, Christopher J.A. Pugh, Yaron Rotman, Tracey G. Simon, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Kathryn H. Schmitz. American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology Communications 2023; 7(4) doi: 10.1097/HC9.0000000000000108
|
| 34 |
Yilun Xu, Yaqi Guan, Wenyi Jin, Li Ding, Jinming Wu. WITHDRAWN: Higher appendicular skeletal muscle mass percentage is an independent protective factor for non-alcoholic steatohepatitis and significant fibrosis in male with NAFLD. Gastroenterología y Hepatología 2020; doi: 10.1016/j.gastrohep.2020.05.020
|
| 35 |
Shira Zelber-Sagi, Federico Salomone, Ilana Kolodkin-Gal, Noam Erez, Assaf Buch, Hanny Yeshua, Muriel Webb, Zamir Halpern, Oren Shibolet. Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease. Digestive and Liver Disease 2017; 49(5): 523 doi: 10.1016/j.dld.2017.01.148
|
| 36 |
Anne Fougerat, Alexandra Montagner, Nicolas Loiseau, Hervé Guillou, Walter Wahli. Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease. Cells 2020; 9(7): 1638 doi: 10.3390/cells9071638
|
| 37 |
Ambrin Farizah Babu, Susanne Csader, Johnson Lok, Carlos Gómez-Gallego, Kati Hanhineva, Hani El-Nezami, Ursula Schwab. Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis. Nutrients 2021; 13(9): 3135 doi: 10.3390/nu13093135
|
| 38 |
Junjie Xiao, Yihua Bei, Jingqi Liu, Jasmina Dimitrova‐Shumkovska, Dapeng Kuang, Qiulian Zhou, Jin Li, Yanning Yang, Yang Xiang, Fei Wang, Changqing Yang, Wenzhuo Yang. miR‐212 downregulation contributes to the protective effect of exercise against non‐alcoholic fatty liver via targeting FGF‐21. Journal of Cellular and Molecular Medicine 2016; 20(2): 204 doi: 10.1111/jcmm.12733
|
| 39 |
Pankaj Puri, Narendra Kotwal. An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist. Journal of Clinical and Experimental Hepatology 2022; 12(2): 560 doi: 10.1016/j.jceh.2021.09.010
|
| 40 |
Emilio Molina‐Molina, Raquel Lunardi Baccetto, David Q.‐H. Wang, Ornella de Bari, Marcin Krawczyk, Piero Portincasa. Exercising the hepatobiliary‐gut axis. The impact of physical activity performance. European Journal of Clinical Investigation 2018; 48(8) doi: 10.1111/eci.12958
|
| 41 |
Georgios Tsamos, Dimitra Vasdeki, Theocharis Koufakis, Vassiliki Michou, Kali Makedou, Georgios Tzimagiorgis. Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes. Metabolites 2023; 13(4): 517 doi: 10.3390/metabo13040517
|
| 42 |
Hans-Theo Schon, Ralf Weiskirchen. Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00283
|
| 43 |
Mariangela Rondanelli, Clara Gasparri, Claudia Razza, Cinzia Ferraris, Simone Perna, Ilaria Ferrarotti, Angelo Guido Corsico. Practical dietary advices for subjects with alpha-1 antitrypsin deficiency. Biomedicine & Pharmacotherapy 2023; 163: 114753 doi: 10.1016/j.biopha.2023.114753
|
| 44 |
Elke Roeb. Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review. Visceral Medicine 2022; 38(2): 126 doi: 10.1159/000519611
|
| 45 |
Veera Houttu, Ulrika Boulund, Aldo Grefhorst, Maarten R. Soeters, Sara-Joan Pinto-Sietsma, Max Nieuwdorp, Adriaan G. Holleboom. The role of the gut microbiome and exercise in non-alcoholic fatty liver disease. Therapeutic Advances in Gastroenterology 2020; 13: 175628482094174 doi: 10.1177/1756284820941745
|
| 46 |
Shira Zelber‐Sagi, Shahar Azar, Alina Nemirovski, Muriel Webb, Zamir Halpern, Oren Shibolet, Joseph Tam. Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease. Obesity 2017; 25(1): 94 doi: 10.1002/oby.21687
|
| 47 |
Nuria Perez-Diaz-del-Campo, Bertha Araceli Marin-Alejandre, Irene Cantero, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, Itziar Abete, M. Angeles Zulet. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study. European Journal of Nutrition 2021; 60(6): 3043 doi: 10.1007/s00394-020-02476-x
|
| 48 |
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, Mohammad Zulqurnain Haider, Mohammed Imad Malki, Abdel-Naser Elzouki. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1291501
|
| 49 |
Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas J G Chase, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Dominic Fritche, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021; 2021(6) doi: 10.1002/14651858.CD013156.pub2
|
| 50 |
Mariana Verdelho Machado. Aerobic Exercise in the Management of Metabolic Dysfunction Associated Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 3627 doi: 10.2147/DMSO.S304357
|
| 51 |
Bo Kyung Koo, Donghee Kim, Sae Kyung Joo, Jung Ho Kim, Mee Soo Chang, Byeong Gwan Kim, Kook Lae Lee, Won Kim. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. Journal of Hepatology 2017; 66(1): 123 doi: 10.1016/j.jhep.2016.08.019
|
| 52 |
Tiziana Fernández, Macarena Viñuela, Catalina Vidal, Francisco Barrera, Pavel Strnad. Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. PLOS ONE 2022; 17(2): e0263931 doi: 10.1371/journal.pone.0263931
|
| 53 |
Oh Young Kwon, Jin-young Choi, Yeonsoo Jang. The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis. Journal of Medical Internet Research 2023; 25: e37487 doi: 10.2196/37487
|
| 54 |
Sunyoung Kang, Min Kyong Moon, Won Kim, Bo Kyung Koo. Association between muscle strength and advanced fibrosis in non‐alcoholic fatty liver disease: a Korean nationwide survey. Journal of Cachexia, Sarcopenia and Muscle 2020; 11(5): 1232 doi: 10.1002/jcsm.12598
|
| 55 |
Shelley E. Keating, Daniel A. Hackett, Helen M. Parker, Kimberley L. Way, Helen T. O'Connor, Amanda Sainsbury, Michael K. Baker, Vivienne H. Chuter, Ian D. Caterson, Jacob George, Nathan A. Johnson. Effect of resistance training on liver fat and visceral adiposity in adults with obesity: A randomized controlled trial. Hepatology Research 2017; 47(7): 622 doi: 10.1111/hepr.12781
|
| 56 |
Christian von Loeffelholz, Johannes Roth, Sina Coldewey, Andreas Birkenfeld. The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease. Biomedicines 2021; 9(12): 1853 doi: 10.3390/biomedicines9121853
|
| 57 |
Shira Zelber-Sagi, Justyna Godos, Federico Salomone. Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. Therapeutic Advances in Gastroenterology 2016; 9(3): 392 doi: 10.1177/1756283X16638830
|
| 58 |
Zobair M. Younossi, Shira Zelber-Sagi, Linda Henry, Lynn H. Gerber. Lifestyle interventions in nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology 2023; 20(11): 708 doi: 10.1038/s41575-023-00800-4
|
| 59 |
Dirk J. van der Windt, Vikas Sud, Hongji Zhang, Allan Tsung, Hai Huang. The Effects of Physical Exercise on Fatty Liver Disease. Gene Expression 2018; 18(2): 89 doi: 10.3727/105221617X15124844266408
|
| 60 |
Xiao-Ni Chai, Bing-Qian Zhou, Ni Ning, Ting Pan, Fan Xu, Si-Han He, Ni-Ni Chen, Mei Sun. Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysis. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1081096
|
| 61 |
Dimitrios Papandreou, Eleni Andreou. Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World Journal of Hepatology 2015; 7(3): 575-582 doi: 10.4254/wjh.v7.i3.575
|
| 62 |
Hao Su, Dongsen Liu, Jia Shao, Yinuo Li, Xiaoxia Wang, Qi Gao. Aging Liver: Can Exercise be a Better Way to Delay the Process than Nutritional and Pharmacological Intervention? Focus on Lipid Metabolism. Current Pharmaceutical Design 2020; 26(39): 4982 doi: 10.2174/1381612826666200605111232
|
| 63 |
Rosamar E.F. Rezende, Sebastião M.B. Duarte, Jose T. Stefano, Hamilton Roschel, Bruno Gualano, Ana L. de Sá Pinto, Denise C.P. Vezozzo, Flair J. Carrilho, Claudia P. Oliveira. Randomized clinical trial: benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease. Menopause 2016; 23(8): 876 doi: 10.1097/GME.0000000000000647
|
| 64 |
N A Smart, N King, J R McFarlane, P L Graham, G Dieberg. Effect of exercise training on liver function in adults who are overweight or exhibit fatty liver disease: a systematic review and meta-analysis. British Journal of Sports Medicine 2018; 52(13): 834 doi: 10.1136/bjsports-2016-096197
|
| 65 |
Jing Zeng, Jian‐Gao Fan, Sven M. Francque. Therapeutic management of metabolic dysfunction associated steatotic liver disease. United European Gastroenterology Journal 2024; 12(2): 177 doi: 10.1002/ueg2.12525
|
| 66 |
Miikka-Juhani Honka, Marco Bucci, Jonathan Andersson, Ville Huovinen, Maria Angela Guzzardi, Samuel Sandboge, Nina Savisto, Minna K. Salonen, Robert M. Badeau, Riitta Parkkola, Joel Kullberg, Patricia Iozzo, Johan G. Eriksson, Pirjo Nuutila. Resistance training enhances insulin suppression of endogenous glucose production in elderly women. Journal of Applied Physiology 2016; 120(6): 633 doi: 10.1152/japplphysiol.00950.2015
|
| 67 |
Christina N Katsagoni, Michael Georgoulis, George V Papatheodoridis, Demosthenes B Panagiotakos, Meropi D Kontogianni. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis. Metabolism 2017; 68: 119 doi: 10.1016/j.metabol.2016.12.006
|
| 68 |
E. Roeb, A. Canbay, H. Bantel, J. Bojunga, J. de Laffolie, M. Demir, U. W. Denzer, A. Geier, W. P. Hofmann, C. Hudert, T. Karlas, M. Krawczyk, T. Longerich, T. Luedde, M. Roden, J. Schattenberg, M. Sterneck, A. Tannapfel, P. Lorenz, F. Tacke. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025. Zeitschrift für Gastroenterologie 2022; 60(09): 1346 doi: 10.1055/a-1880-2283
|
| 69 |
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025. Zeitschrift für Gastroenterologie 2022; 60(09): e733 doi: 10.1055/a-1880-2388
|
| 70 |
Kazem Ranjbar, Hassan Matin Homaie, Mohammad Ali Azarbayjani, Maghsoud Piri. The Effect of Gallic Acid Supplement and Resistance Exercise on the Bio-markers of Liver in Intoxicated Male Rats of Anabolic Steroid. Medical Laboratory Journal 2020; 14(1): 44 doi: 10.29252/mlj.14.1.44
|
| 71 |
Shelley E. Keating, Angelo Sabag, Kate Hallsworth, Ingrid J. Hickman, Graeme A. Macdonald, Jonathan G. Stine, Jacob George, Nathan A. Johnson. Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia. Sports Medicine 2023; 53(12): 2347 doi: 10.1007/s40279-023-01918-w
|
| 72 |
Ryuki Hashida, Takumi Kawaguchi, Masafumi Bekki, Masayuki Omoto, Hiroo Matsuse, Takeshi Nago, Yoshio Takano, Takato Ueno, Hironori Koga, Jacob George, Naoto Shiba, Takuji Torimura. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. Journal of Hepatology 2017; 66(1): 142 doi: 10.1016/j.jhep.2016.08.023
|
| 73 |
Marie Boyle, Quentin M. Anstee. Evidence‐based Gastroenterology and Hepatology 4e. 2019; : 523 doi: 10.1002/9781119211419.ch35
|
| 74 |
J. A. Russell-Guzmán, L. Karachon, T. A. Gacitúa, A. Freundlich, C. E. Poblete-Aro, R. Rodrigo. Role of exercise in the mechanisms ameliorating hepatic steatosis in non-alcoholic fatty liver disease. Sport Sciences for Health 2018; 14(3): 463 doi: 10.1007/s11332-018-0459-9
|
| 75 |
Robinson Ramírez-Vélez, Mikel Izquierdo, Jorge Correa-Bautista, Alejandra Tordecilla-Sanders, María Correa-Rodríguez, Jacqueline Schmidt Rio-Valle, Emilio González-Jiménez, Katherine González-Ruíz. Grip Strength Moderates the Association between Anthropometric and Body Composition Indicators and Liver Fat in Youth with an Excess of Adiposity. Journal of Clinical Medicine 2018; 7(10): 347 doi: 10.3390/jcm7100347
|
| 76 |
Shira Zelber-Sagi, Shiran Bord, Gali Dror-Lavi, Matthew Lee Smith, Samuel D Towne Jr, Assaf Buch, Muriel Webb, Hanny Yeshua, Assy Nimer, Oren Shibolet. Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients. World Journal of Gastroenterology 2017; 23(10): 1881-1890 doi: 10.3748/wjg.v23.i10.1881
|
| 77 |
Gabriel Scarlat, Bassil Dona, Mihai Cârstea, Marilena Stoian. Insights into Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Internal Medicine 2022; 19(1): 61 doi: 10.2478/inmed-2022-0198
|
| 78 |
Min‐Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kim, Joo Sung Kim. The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease. Liver International 2017; 37(6): 919 doi: 10.1111/liv.13332
|
| 79 |
Soheila Jangjo-Borazjani, Maryam Dastgheib, Efat Kiyamarsi, Roghayeh Jamshidi, Saleh Rahmati-Ahmadabad, Masoumeh Helalizadeh, Roya Iraji, Stephen M Cornish, Shiva Mohammadi-Darestani, Zohreh Khojasteh, Mohammad Ali Azarbayjani. Effects of resistance training and nigella sativa on type 2 diabetes: implications for metabolic markers, low-grade inflammation and liver enzyme production. Archives of Physiology and Biochemistry 2023; 129(4): 913 doi: 10.1080/13813455.2021.1886117
|
| 80 |
S Sherf-Dagan, S Zelber-Sagi, G Zilberman-Schapira, M Webb, A Buch, A Keidar, A Raziel, N Sakran, D Goitein, N Goldenberg, J A Mahdi, M Pevsner-Fischer, N Zmora, M Dori-Bachash, E Segal, E Elinav, O Shibolet. Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial. International Journal of Obesity 2018; 42(2): 147 doi: 10.1038/ijo.2017.210
|
| 81 |
Francesca Battista, Andrea Ermolao, Marleen A. van Baak, Kristine Beaulieu, John E. Blundell, Luca Busetto, Eliana V. Carraça, Jorge Encantado, Dror Dicker, Nathalie Farpour‐Lambert, Adriyan Pramono, Alice Bellicha, Jean‐Michel Oppert. Effect of exercise on cardiometabolic health of adults with overweight or obesity: Focus on blood pressure, insulin resistance, and intrahepatic fat—A systematic review and meta‐analysis. Obesity Reviews 2021; 22(S4) doi: 10.1111/obr.13269
|
| 82 |
W. Timothy Garvey, Jeffrey I. Mechanick, Elise M. Brett, Alan J. Garber, Daniel L. Hurley, Ania M. Jastreboff, Karl Nadolsky, Rachel Pessah-Pollack, Raymond Plodkowski. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity. Endocrine Practice 2016; 22: 1 doi: 10.4158/EP161365.GL
|
| 83 |
Rohit Loomba, Helena Cortez-Pinto. Exercise and improvement of NAFLD: Practical recommendations. Journal of Hepatology 2015; 63(1): 10 doi: 10.1016/j.jhep.2015.03.009
|
| 84 |
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocrine Reviews 2020; 41(1): 66 doi: 10.1210/endrev/bnz009
|
| 85 |
Andrea Gonzalez, Mayalen Valero-Breton, Camila Huerta-Salgado, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis. European Journal of Translational Myology 2021; doi: 10.4081/ejtm.2021.9630
|
| 86 |
Tian-Tian Zou, Chao Zhang, Yi-Fan Zhou, Yi-Jing Han, Jiao-Jiao Xiong, Xi-Xi Wu, Yong-Ping Chen, Ming-Hua Zheng. Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis. European Journal of Gastroenterology & Hepatology 2018; 30(7): 747 doi: 10.1097/MEG.0000000000001135
|
| 87 |
Alia Hadefi, Marianna Arvanitakis, Eric Trépo, Shira Zelber‐Sagi. Dietary strategies in non‐alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review. United European Gastroenterology Journal 2023; 11(7): 663 doi: 10.1002/ueg2.12443
|
| 88 |
Johannes Weiss. Nicht-alkoholische Fettlebererkrankung. 2022; : 189 doi: 10.1007/978-3-662-62484-5_18
|
| 89 |
Maureen Whitsett, Lisa B VanWagner. Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review. World Journal of Hepatology 2015; 7(16): 2041-2052 doi: 10.4254/wjh.v7.i16.2041
|
| 90 |
José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Renato Gama Ribeiro Leite Altikes, Claudia P. Oliveira. Non-pharmacological management options for MAFLD: a practical guide. Therapeutic Advances in Endocrinology and Metabolism 2023; 14: 204201882311603 doi: 10.1177/20420188231160394
|
| 91 |
Ebaa Al Ozairi, Dalal Alsaeed, Dherar Al Roudhan, Mohammed Jalali, Anant Mashankar, Dennis Taliping, Amal Abdulla, Jason M. R. Gill, Naveed Sattar, Paul Welsh, Stuart R. Gray. The effect of home‐based resistance exercise training in people with type 2 diabetes: A randomized controlled trial. Diabetes/Metabolism Research and Reviews 2023; 39(7) doi: 10.1002/dmrr.3677
|
| 92 |
C. Moctezuma-Velázquez. Current treatment for non-alcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 2018; 83(2): 125 doi: 10.1016/j.rgmxen.2018.05.014
|
| 93 |
Tom Cormier. Exercise Programming for Nonalcoholic Fatty Liver Disease. Strength & Conditioning Journal 2019; 41(4): 89 doi: 10.1519/SSC.0000000000000462
|
| 94 |
Erin M. McCarthy, Mary E. Rinella. Lifestyle Medicine. 2016; : 321 doi: 10.1007/978-3-319-24687-1_29
|